Gerresheimer AG: High-Quality Assets in Distress – A Turnaround Bet Amidst Financial Turmoil
Overview
Gerresheimer AG stands at a precarious inflection point. It combines a storied industrial franchise with strong market positions in pharma packaging and a technical edge in drug delivery devices, but is weighed down by balance sheet distress and the fallout from over-aggressive expansion. The collapse in its legacy Moulded Glass business, coupled with the timing of the debt-funded Bormioli acquisition, has led to severe financial stress and a sharp management reset. The company now trades at deep distress multiples, making the investment case a high-risk/high-reward call option on successful restructuring. The focus has shifted resolutely from top-line growth to urgent cash flow stabilization and capital structure repair.